Once-daily dose of glaucoma drug omidenepag isopropyl offers similar benefit as two doses
- Posted on: Nov 26 2021
- Leave a response
A once-daily dose of the novel drug omidenepag isopropyl showed the same efficacy as twice-daily dosing and was more tolerable for patients.
Source: AAO
Posted in: Uncategorized
